Genoil (GNOLF) Capital Expenditures (2009 - 2013)

Genoil (GNOLF) has reported Capital Expenditures for 5 consecutive years, with $0.95 the latest figure, recorded in Q4 2013.

• On a quarterly basis, Capital Expenditures rose 100.0% year-over-year to $0.95 in Q4 2013; TTM through Sep 2016 was $0.95, a N/A change from a year earlier, with the FY2013 full-year figure at -$1930.6, up 94.88% from the prior year.
• Capital Expenditures was $0.95 for Q4 2013 at Genoil, up from -$1974.1 in the prior quarter.
• Over five years, Capital Expenditures peaked at $57657.6 in Q3 2012 and troughed at -$115751.8 in Q4 2011.
• A 5-year average of -$21065.0 and a median of -$3115.9 in 2010 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures tumbled 1250.67% in 2011 and soared 200.26% in 2012, its largest moves.
• Over 5 years, Capital Expenditures stood at $1330.8 in 2009, then slumped by 419.93% to -$4257.6 in 2010, then slumped by 2618.7% to -$115751.8 in 2011, then jumped by 36.99% to -$72931.6 in 2012, then jumped by 100.0% to $0.95 in 2013.
• The last three Capital Expenditures figures came in at $0.95 (Q4 2013), -$1974.1 (Q1 2013), and -$72931.6 (Q4 2012), per Business Quant data.